StonvexLoading…
StonvexStonvexStonvexCore line items from NUTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $875.26M | $479.95M | $247.65M | $219.29M |
Operating Income | $275.63M | $130.70M | $-31.77M | $-406.60M |
Net Income | $70.79M | $52.10M | $-45.79M | $-424.78M |
EPS (Diluted) | $10.48 | $9.69 | $-10.39 | $-100.36 |
Total Assets | $918.52M | $655.32M | $398.25M | $431.75M |
Total Liabilities | $495.09M | $466.79M | $319.14M | $311.42M |
Cash & Equivalents | $185.57M | $40.64M | $22.00M | $34.26M |
Free Cash Flow OCF − CapEx | $245.60M | $20.85M | $-8.24M | $35.97M |
Shares Outstanding | 7.09M | 5.51M | 4.51M | 4.33M |